Literature DB >> 1831909

Effects of tianeptine on stress-induced behavioural deficits and 5-HT dependent behaviour.

P S Whitton1, G S Sarna, K P Datla, G Curzon.   

Abstract

The novel tricyclic antidepressant drug tianeptine had an antidepressant-like effect on a rat model of depression based on the deficit in open field activity observed on the day after 2 h restraint. Thus, when tianeptine (10 mg/kg IP) was given 2 h after the end of the restraint to either untreated rats or to animals previously given 10 mg/kg of the drug per day for 13 days, then the deficit was opposed. Tianeptine, given acutely but not chronically, moderately enhanced the 5-HT1C receptor-dependent hypolocomotor effect of m-chlorophenylpiperazine (mCPP) but did not alter other 5-HT1 receptor subtype-dependent behaviour. Acute but not chronic tianeptine also decreased 5-HT2 receptor-dependent body shakes induced by 5-hydroxytryptophan. Shakes induced by the 5-HT2 agonist 1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane (DOI) were unaffected. The results are discussed in relation to the possible mechanism of antidepressant action of tianeptine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831909     DOI: 10.1007/bf02244558

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  "Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity.

Authors:  P Bedard; C J Pycock
Journal:  Neuropharmacology       Date:  1977-10       Impact factor: 5.250

2.  Depression.

Authors:  H M van Praag
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

Review 3.  Neurochemical profile of tianeptine, a new antidepressant drug.

Authors:  G Kato; A F Weitsch
Journal:  Clin Neuropharmacol       Date:  1988       Impact factor: 1.592

Review 4.  A role for 5-HT in the action of antidepressant drugs.

Authors:  P J Cowen
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

5.  Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

Authors:  G R Heninger; D S Charney; D E Sternberg
Journal:  Arch Gen Psychiatry       Date:  1984-04

6.  Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression.

Authors:  G A Kennett; C T Dourish; G Curzon
Journal:  Eur J Pharmacol       Date:  1987-02-24       Impact factor: 4.432

7.  5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues.

Authors:  R A Glennon; J D McKenney; R A Lyon; M Titeler
Journal:  J Med Chem       Date:  1986-02       Impact factor: 7.446

8.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

9.  Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.

Authors:  J Arnt; J Hyttel
Journal:  Eur J Pharmacol       Date:  1989-02-14       Impact factor: 4.432

10.  Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.

Authors:  P H Hutson; C T Dourish; G Curzon
Journal:  Eur J Pharmacol       Date:  1986-10-07       Impact factor: 4.432

View more
  6 in total

Review 1.  Tianeptine: a review of its use in depressive disorders.

Authors:  A J Wagstaff; D Ormrod; C M Spencer
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry.

Authors:  B Saletu; J Grünberger; P Anderer; L Linzmayer; G Zyhlarz
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents.

Authors:  Alison C Shakesby; Roger Anwyl; Michael J Rowan
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 4.  Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.

Authors:  M I Wilde; P Benfield
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

5.  Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.

Authors:  Irena Smaga; Beata Bystrowska; Dawid Gawliński; Bartosz Pomierny; Piotr Stankowicz; Małgorzata Filip
Journal:  Neurotox Res       Date:  2014-03-21       Impact factor: 3.911

Review 6.  The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.

Authors:  B S McEwen; S Chattarji; D M Diamond; T M Jay; L P Reagan; P Svenningsson; E Fuchs
Journal:  Mol Psychiatry       Date:  2009-08-25       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.